The incidence of RSV across 5 respiratory virus seasons was substantial among adult patients with high-risk underlying conditions.

These populations are still included in the CDC’s COVID-19 immunization schedules despite the HHS secretary saying the shots ...

Adults with RSV-associated acute respiratory infection face a 2.7-fold higher risk for death within one year, according to a ...

A statewide immunization program for infants against respiratory syncytial virus (RSV), which began in 2024, has already ...

COVID-19 indicators have fallen to their lowest levels since early summer 2024 after very low levels that spring. Cases and ...

The new three-illness dashboard includes a history of outbreaks for any or all of the three respiratory illnesses. It ...

Respiratory syncytial virus (RSV) is the number one cause of hospitalization in infants, accounting for about 25% of all ...

New prevention measures for RSV have led to a major drop in hospitalizations among infants, according to a new CDC study.

Vaccine advisers to the FDA decided Thursday that only strains of the JN.1 variant should be targeted by updated versions of covid vaccines that will be available next fall and winter. Separately, ...

Infections from respiratory syncytial virus (RSV) in children requiring primary care led to significant societal economic costs from outpatient treatment and parental work absences in Europe, ...

The notion that we should require placebo trials even when there's already a safe, effective vaccine goes against decades of ...

Six public health departments in Michigan were using federal funds to expand testing for disease and even guard against ...